|
Volumn 26, Issue 2 SUPPL. 7, 1999, Pages 61-65
|
Use of amifostine in hematologic malignancies, myelodysplastic syndrome, and acute leukemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (3 AMINOPROPYLAMINO)ETHANETHIOL;
AMIFOSTINE;
BIS[2 (3 AMINOPROPYLAMINO)ETHYL] DISULFIDE;
ACUTE LEUKEMIA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CELL DIFFERENTIATION;
CELL KILLING;
COLONY FORMING UNIT;
CONTROLLED STUDY;
DOG;
DRUG EFFECT;
ENZYME ACTIVITY;
HEMATOLOGIC DISEASE;
MYELODYSPLASTIC SYNDROME;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
STEM CELL;
ACUTE DISEASE;
AMIFOSTINE;
ANIMALS;
APOPTOSIS;
CYTOPROTECTION;
HEMATOLOGIC NEOPLASMS;
HEMATOPOIETIC STEM CELLS;
HUMANS;
LEUKEMIA;
MERCAPTOETHYLAMINES;
MOLECULAR STRUCTURE;
MYELODYSPLASTIC SYNDROMES;
PROTECTIVE AGENTS;
SPERMIDINE;
SPERMINE;
|
EID: 0032994129
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (34)
|
References (30)
|